In non-small cell lung cancer, SMYD3 binds to the anoctamin-1 (ANO1) promoter region, which is enriched with H3K4me3, thereby increasing ANO1 transcription and regulating cancer cell proliferation74. This evidence concerns the gene ANO1 and cancer.